Vivos Inc. Announces Listing to the OTCQB
18 sept. 2019 07h00 HE
|
Vivos Inc.
Richland WA, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. a company engaged in the development and commercialization of minimally invasive brachytherapy treatments to...
Vivos Inc. Stock Symbol Reverts to RDGL University of Missouri Report Near Completion
29 juil. 2019 07h00 HE
|
Vivos Inc.
Richland WA, July 29, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGL), stock symbol reverts back to RDGL effective with the open of trading on Monday, July 29. As previously disclosed, the D at...
Vivos Inc. Pilot Clinic Completes First IsoPet® Therapy
11 juil. 2019 07h00 HE
|
Vivos Inc.
Richland WA, July 11, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD), Dr. Michelle Meyers, IsoPet® certified veterinarian practicing at Vista Veterinary Hospital, treated their first patient,...
Vivos Inc. Pilot Clinic Completes Their Certification Training
09 juil. 2019 07h00 HE
|
Vivos Inc.
Richland WA, July 09, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD) Vivos, Inc. is pleased to announce that Vista Veterinary Hospital has completed its first Isopet® certification training...
Vivos Inc. Enhances its Intellectual Property Protection
02 juil. 2019 07h00 HE
|
Vivos Inc.
Richland WA, July 02, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD), Vivos today announced the filing of a patent application covering key aspects of its technology and propriety...
Vivos Inc. Issues Corrective Press Release Regarding Reverse Stock Split
27 juin 2019 15h07 HE
|
Vivos Inc.
Richland, WA, June 27, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...
Vivos Inc. Announces 1-for-8 Reverse Stock Split
26 juin 2019 07h00 HE
|
Vivos Inc.
Richland, WA, June 26, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...
Vivos Inc. Summarizes the Health of Canine Therapy Patients Treated with IsoPet
04 mars 2019 07h00 HE
|
Vivos Inc.
Richland WA, March 04, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTCPINK: RDGL), provides a summary of the previous update on dogs that have been treated to date in the canine soft tissue sarcoma...
Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet®
04 déc. 2018 15h50 HE
|
Vivos Inc.
Richland, WA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc. Reports Strong Reception to IsoPet® At Veterinary Cancer Society Conference
22 oct. 2018 07h00 HE
|
Vivos Inc.
Richland WA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to report that its attendance and presentation at the annual meeting of the Veterinary Cancer Society...